Download presentation
Presentation is loading. Please wait.
Published byMerryl Clarke Modified over 6 years ago
1
Sociodemographic disparities in the utilization of proton therapy for prostate cancer at an urban academic center Kristina D. Woodhouse, MD, Wei-Ting Hwang, PhD, Neha Vapiwala, MD, Akansha Jain, Xingmei Wang, MS, Stefan Both, PhD, Meera Shah, BS, Marquise Frazier, RT(T), MBA, Peter Gabriel, MD, John P. Christodouleas, MD, MPH, Zelig Tochner, MD, Curtiland Deville, MD Advances in Radiation Oncology Volume 2, Issue 2, Pages (April 2017) DOI: /j.adro Copyright © 2017 The Authors on behalf of the American Society for Radiation Oncology Terms and Conditions
2
Figure 1 Univariable and multivariable analysis of proton therapy use for low- and intermediate-risk prostate cancer by race, age, distance, and poverty. Advances in Radiation Oncology 2017 2, DOI: ( /j.adro ) Copyright © 2017 The Authors on behalf of the American Society for Radiation Oncology Terms and Conditions
3
Figure 2 Percentage use of proton therapy versus intensity modulated radiation therapy per treatment year ( ) for low- and intermediate risk prostate cancer. *Significant difference and error bars represent the 95% confidence interval. Advances in Radiation Oncology 2017 2, DOI: ( /j.adro ) Copyright © 2017 The Authors on behalf of the American Society for Radiation Oncology Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.